Eli Lilly seeks $24 million in tax abatements for renovations and expansion
Eli Lilly and Co. is seeking an estimated $24 million in tax abatements from Indianapolis to expand diabetes therapy production. |!| Indianapolis
Eli Lilly and Co. is seeking an estimated $24 million in tax abatements from Indianapolis to expand diabetes therapy production. |!| Indianapolis